News
Mexico patent protection granted
Mexican patent office grants patent protection for Vigorous Solutions fast-acting sildenafil solutions
Read MoreChina patent protection granted
Chinese National Intellectual Property Administration grants patent protection for Vigorous Solutions novel fast-acting sildenafil solutions
Read MorePatent protection granted for Eurasian countries
Eurasian patent protection for Vigorous Solutions sildenafil solutions is granted in Russia, Turkmenistan, Belarus, Tajikistan, Azerbaijan, Kazakhstan, Kyrgyzstan, and Armenia
Read MorePatent granted in Israel
Israel Patent Authority issues notice of allowance for Vigorous Solutions novel sildenafil solution products
Read MoreSecond Clinical Trial Completed
Second pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation as the fastest absorbed and highest bioavailable Sildenafil product
Read MoreSecond U.S. Patent Granted
Vigorous Solutions receives a second U.S. patent allowance, issued to expand the protection of its proprietary liquid sildenafil formulations
Read MoreFirst U.S. Patent Granted
Vigorous Solutions is issued its first U.S. patent allowance, covering an expansive variety of liquid solutions
Read MoreEuropean Patent Registration Complete
European patent registers Vigorous Solutions product in all 38 European countries
Read MoreEuropean Patent Allowance
Grant Patent issued to Vigorous Solutions by the European Patent Office
Read MoreFirst Clinical Trial Completed
First pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation’s superiority in time-to-absorption vs Pfizer’s Viagra®.
Read More